Literature DB >> 18052729

Cross-inhibition of interferon-induced signals by GM-CSF through a block in Stat1 activation.

Stefan Kasper1, Thomas Kindler, Sebastian Sonnenschein, Frank Breitenbuecher, Frank D Böhmer, Christoph Huber, Thomas Fischer.   

Abstract

We investigated the effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) on biologic signals induced by interferon-alpha (IFN-alpha) and IFN-gamma. In hematopoietic cell lines, IFN-induced signaling was investigated by Western blotting, electrophoretic mobility shift assays (EMSA), flow cytometry, protein-tyrosine phosphatase (PTP) assays, and RT-PCR. GM-CSF inhibited IFN-alpha-induced and IFN-gamma-induced Stat1 tyrosine phosphorylation in a time-dependent manner. EMSA showed that GM-CSF inhibited IFN-alpha-induced and IFN-gamma-induced IFN-gamma activator sequence (GAS) binding activity. As a consequence, IFN-induced transcription of the early response gene, IFN-stimulated gene 54 (ISG54), was inhibited. The expression of IFN regulatory factor-1 (IRF-1) and MHC class I antigens was downregulated at protein levels in hematopoietic cell lines (U937, THP1). In contrast to GM-CSF, granulocyte colony-stimulating factor (G-CSF) and interleukin-3 (IL-3) did not influence the IFN-induced Stat1 activation. To explore the molecular mechanism of suppression of Stat1 tyrosine phosphorylation, we investigated the induction and activation of cytokine-inducible SH2-containing protein/suppressor of cytokine signaling (CIS/SOCS) molecules and phosphatases on GM-CSF treatment. In contrast to G-CSF and IL-3, GM-CSF strongly induced the expression of CIS1 and SOCS2 at mRNA levels, but overexpression of CIS1 or SOCS2 in HEK293 cells did not show inhibition of Stat1 tyrosine phosphorylation upon IFN treatment. In PTP assays, on GM-CSF incubation, no enhanced src homology 2 domain tyrosine phosphatase 1 and 2 (SHP1 and SHP2) activity was detectable. However, GM-CSF-induced downregulation of Tyk2 and Jak1 tyrosine phosphorylation as well as Tyk2 protein levels likely contributed to the reduced Stat1 tyrosine phosphorylation. In hematopoietic cells, GM-CSF antagonizes IFN-induced signals by a block in Stat1 activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18052729     DOI: 10.1089/jir.2006.0170

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  5 in total

1.  Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies.

Authors:  S Kasper; F Breitenbuecher; F Heidel; S Hoffarth; B Markova; M Schuler; T Fischer
Journal:  Blood Cancer J       Date:  2012-03-09       Impact factor: 11.037

Review 2.  The Role of Inflammatory Cytokines in the Pathogenesis of Colorectal Carcinoma-Recent Findings and Review.

Authors:  Jędrzej Borowczak; Krzysztof Szczerbowski; Mateusz Maniewski; Adam Kowalewski; Marlena Janiczek-Polewska; Anna Szylberg; Andrzej Marszałek; Łukasz Szylberg
Journal:  Biomedicines       Date:  2022-07-11

3.  βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer.

Authors:  D C Christoph; S Kasper; T C Gauler; C Loesch; M Engelhard; D Theegarten; C Poettgen; R Hepp; A Peglow; H Loewendick; S Welter; G Stamatis; F R Hirsch; M Schuler; W E E Eberhardt; J Wohlschlaeger
Journal:  Br J Cancer       Date:  2012-07-26       Impact factor: 7.640

4.  Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis.

Authors:  Nichole M Miller; Jun Wang; Yanping Tan; Bonnie N Dittel
Journal:  Front Neurosci       Date:  2015-08-18       Impact factor: 4.677

Review 5.  Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types.

Authors:  In-Sun Hong
Journal:  Exp Mol Med       Date:  2016-07-01       Impact factor: 8.718

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.